Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE · BSE: 532321 · Pharmaceuticals & Biotechnology · 68 announcements

Zydus Lifesciences Ltd news stories on ALFA NewsRead the news →
Share price
₹1,154.00
Market cap
₹1,16,119 Cr
Revenue (annual)
₹27,148 Cr
Net profit (annual)
₹5,040 Cr
P/E (TTM)
25.7×Sector 47.4×
Promoter holding
75.01%+0.01% QoQ
FII holding
6.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:13 IST BSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences' subsidiary, ZPUI, settled an antitrust litigation case for a total payment of USD 5.9 million, without admission of wrongdoing.

Value
₹55.46 Cr
12:27 IST NSE
Legal & Regulatory

Zydus Lifesciences Legal & Regulatory

Zydus Lifesciences received a demand for ₹108.54 Crore in deficient stamp duty and penalties. The company is evaluating legal remedies regarding the order.

Value
₹10.85 Cr